human cd3 mab Search Results


91
Sino Biological anti human cd3e antibody apc
Anti Human Cd3e Antibody Apc, supplied by Sino Biological, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+cd3+mab/Anti-Human+CD3+Antibody%2C+Mouse+MAb/pmc10213811-102-32-36
Average 91 stars, based on 1 article reviews
anti human cd3e antibody apc - by Bioz Stars, 2026-10
91/100 stars
  Buy from Supplier

90
Becton Dickinson anti-human cd3–allophycocyanin mab sk7
Anti Human Cd3–Allophycocyanin Mab Sk7, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+cd3+mab/stimulating+mouse+anti+human+cd3+mab+sk7/10__1128_slash_iai__00355___09-64-20-25
Average 90 stars, based on 1 article reviews
anti-human cd3–allophycocyanin mab sk7 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Schering-Plough corporation mouse anti-human cd3 mab (okt3
Mouse Anti Human Cd3 Mab (Okt3, supplied by Schering-Plough corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+cd3+mab/mouse+anti+human+cd3+mab++okt3/us08512705-765-24-29
Average 90 stars, based on 1 article reviews
mouse anti-human cd3 mab (okt3 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Becton Dickinson cy-chrome-labeled mouse anti-human cd3 mab
Cy Chrome Labeled Mouse Anti Human Cd3 Mab, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+cd3+mab/cy+chrome+labeled+mouse+anti+human+cd3+mab/pm10706672-63-5-13
Average 90 stars, based on 1 article reviews
cy-chrome-labeled mouse anti-human cd3 mab - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Serotech Inc rat anti-human cd3 ε fitc mab
Rat Anti Human Cd3 ε Fitc Mab, supplied by Serotech Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+cd3+mab/anti+human+cd3+mab/pmc04693900-117-7-16
Average 90 stars, based on 1 article reviews
rat anti-human cd3 ε fitc mab - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Immunotec inc biotinylated mab directed against human cd3 antibody
Biotinylated Mab Directed Against Human Cd3 Antibody, supplied by Immunotec inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+cd3+mab/biotinylated+mab+directed+against+human+cd3+antibody/pm08516559-34-8-13
Average 90 stars, based on 1 article reviews
biotinylated mab directed against human cd3 antibody - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Becton Dickinson mouse anti-human cd3 zeta antibody
Mouse Anti Human Cd3 Zeta Antibody, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+cd3+mab/mouse+anti+human+cd3+%CE%B6+mab/pm17024231-55-24-29
Average 90 stars, based on 1 article reviews
mouse anti-human cd3 zeta antibody - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Immunotec inc fluorochrome-conjugated antibodies anti-cd3/fitc im2635
Fluorochrome Conjugated Antibodies Anti Cd3/Fitc Im2635, supplied by Immunotec inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+cd3+mab/pe+cy5+conjugated+mouse+anti+human+cd3+mab+im2635u/pmc04177855-60-12-14
Average 90 stars, based on 1 article reviews
fluorochrome-conjugated antibodies anti-cd3/fitc im2635 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Becton Dickinson mab anti-human cd3 alexa fluor 700-a labelled
PBMC from healthy blood donors and T1D patients, were GAD65 AA 114–122 peptide stimulated, stained with <t>CD3,</t> CD8 and GAD65 AA 114–122 HLA A*02:01 pentamers, then analyzed by FACS to determine the percentages of GAD65 pentamer reactive cells in <t>CD3</t> + CD8 bright , CD3 + CD8 dull , total CD3 + CD8 + and CD3 - CD8 dull subsets (see ). In the graph, horizontal bars represent the mean percentage of CD3 - CD8 dull GAD65 AA 114–122 reactive cells and each symbol represents an individual: circle dots represents the normal and square dots the diabetic. Percentages of CD3 - CD8 dull GAD65 reactive cells refer to analyzed events within flow-cytometry gates as shown in representative dot plots in . GAD65 + = reactive with PE-labelled GAD65 AA 114–122 pentamer. N = number of T1D patients and HD controls analyzed.
Mab Anti Human Cd3 Alexa Fluor 700 A Labelled, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+cd3+mab/mab+anti+human+cd3+alexa+fluor+700+a+labelled/pmc05728516-101-32-44
Average 90 stars, based on 1 article reviews
mab anti-human cd3 alexa fluor 700-a labelled - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Ortho Pharmaceutical Corporation anti-human cd3 mab
PBMC from healthy blood donors and T1D patients, were GAD65 AA 114–122 peptide stimulated, stained with <t>CD3,</t> CD8 and GAD65 AA 114–122 HLA A*02:01 pentamers, then analyzed by FACS to determine the percentages of GAD65 pentamer reactive cells in <t>CD3</t> + CD8 bright , CD3 + CD8 dull , total CD3 + CD8 + and CD3 - CD8 dull subsets (see ). In the graph, horizontal bars represent the mean percentage of CD3 - CD8 dull GAD65 AA 114–122 reactive cells and each symbol represents an individual: circle dots represents the normal and square dots the diabetic. Percentages of CD3 - CD8 dull GAD65 reactive cells refer to analyzed events within flow-cytometry gates as shown in representative dot plots in . GAD65 + = reactive with PE-labelled GAD65 AA 114–122 pentamer. N = number of T1D patients and HD controls analyzed.
Anti Human Cd3 Mab, supplied by Ortho Pharmaceutical Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+cd3+mab/anti+human+cd3+mab/us09243055-605-15-20
Average 90 stars, based on 1 article reviews
anti-human cd3 mab - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Becton Dickinson cy5-labeled mouse anti-human cd3 mab
PBMC from healthy blood donors and T1D patients, were GAD65 AA 114–122 peptide stimulated, stained with <t>CD3,</t> CD8 and GAD65 AA 114–122 HLA A*02:01 pentamers, then analyzed by FACS to determine the percentages of GAD65 pentamer reactive cells in <t>CD3</t> + CD8 bright , CD3 + CD8 dull , total CD3 + CD8 + and CD3 - CD8 dull subsets (see ). In the graph, horizontal bars represent the mean percentage of CD3 - CD8 dull GAD65 AA 114–122 reactive cells and each symbol represents an individual: circle dots represents the normal and square dots the diabetic. Percentages of CD3 - CD8 dull GAD65 reactive cells refer to analyzed events within flow-cytometry gates as shown in representative dot plots in . GAD65 + = reactive with PE-labelled GAD65 AA 114–122 pentamer. N = number of T1D patients and HD controls analyzed.
Cy5 Labeled Mouse Anti Human Cd3 Mab, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+cd3+mab/cy5+labeled+mouse+anti+human+cd3+mab/pmc03499347-251-39-44
Average 90 stars, based on 1 article reviews
cy5-labeled mouse anti-human cd3 mab - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Becton Dickinson 20 ml fitc-conjugated mouse anti-human cd3 mab
PBMC from healthy blood donors and T1D patients, were GAD65 AA 114–122 peptide stimulated, stained with <t>CD3,</t> CD8 and GAD65 AA 114–122 HLA A*02:01 pentamers, then analyzed by FACS to determine the percentages of GAD65 pentamer reactive cells in <t>CD3</t> + CD8 bright , CD3 + CD8 dull , total CD3 + CD8 + and CD3 - CD8 dull subsets (see ). In the graph, horizontal bars represent the mean percentage of CD3 - CD8 dull GAD65 AA 114–122 reactive cells and each symbol represents an individual: circle dots represents the normal and square dots the diabetic. Percentages of CD3 - CD8 dull GAD65 reactive cells refer to analyzed events within flow-cytometry gates as shown in representative dot plots in . GAD65 + = reactive with PE-labelled GAD65 AA 114–122 pentamer. N = number of T1D patients and HD controls analyzed.
20 Ml Fitc Conjugated Mouse Anti Human Cd3 Mab, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+cd3+mab/20+ml+fitc+conjugated+mouse+anti+human+cd3+mab/10__1111_slash_j__1574___695x__2010__00658__x-77-11-24
Average 90 stars, based on 1 article reviews
20 ml fitc-conjugated mouse anti-human cd3 mab - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

Image Search Results


PBMC from healthy blood donors and T1D patients, were GAD65 AA 114–122 peptide stimulated, stained with CD3, CD8 and GAD65 AA 114–122 HLA A*02:01 pentamers, then analyzed by FACS to determine the percentages of GAD65 pentamer reactive cells in CD3 + CD8 bright , CD3 + CD8 dull , total CD3 + CD8 + and CD3 - CD8 dull subsets (see ). In the graph, horizontal bars represent the mean percentage of CD3 - CD8 dull GAD65 AA 114–122 reactive cells and each symbol represents an individual: circle dots represents the normal and square dots the diabetic. Percentages of CD3 - CD8 dull GAD65 reactive cells refer to analyzed events within flow-cytometry gates as shown in representative dot plots in . GAD65 + = reactive with PE-labelled GAD65 AA 114–122 pentamer. N = number of T1D patients and HD controls analyzed.

Journal: PLoS ONE

Article Title: Identification of GAD65 AA 114-122 reactive 'memory-like' NK cells in newly diagnosed Type 1 diabetic patients by HLA-class I pentamers

doi: 10.1371/journal.pone.0189615

Figure Lengend Snippet: PBMC from healthy blood donors and T1D patients, were GAD65 AA 114–122 peptide stimulated, stained with CD3, CD8 and GAD65 AA 114–122 HLA A*02:01 pentamers, then analyzed by FACS to determine the percentages of GAD65 pentamer reactive cells in CD3 + CD8 bright , CD3 + CD8 dull , total CD3 + CD8 + and CD3 - CD8 dull subsets (see ). In the graph, horizontal bars represent the mean percentage of CD3 - CD8 dull GAD65 AA 114–122 reactive cells and each symbol represents an individual: circle dots represents the normal and square dots the diabetic. Percentages of CD3 - CD8 dull GAD65 reactive cells refer to analyzed events within flow-cytometry gates as shown in representative dot plots in . GAD65 + = reactive with PE-labelled GAD65 AA 114–122 pentamer. N = number of T1D patients and HD controls analyzed.

Article Snippet: A subsequent staining procedure for phenotypic characterization of CD3 - CD8 dull GAD65 AA 114–122 pentamer reactive T cells was implemented by adding the following antibodies: mAb anti-human CD8 FITC (1:20, BD), mAb anti-human CD3 Alexa Fluor 700-A labelled (1:50, clone UCHT1, cat# 557943, BD), mouse mAb anti-human CD56 PE cyanine 7 (PECy7) labelled (clone B159, cat# 557747, BD) and mouse mAb anti-human ILT2/LIR1 (CD85J (Ig-like transcript (ILT)/leukocyte Ig-like receptor (LIR) (APC conjugated, clone HP-F1, cat# 17-5129-41, eBioscience) [ ] both used at 1:50 dilution.

Techniques: Staining, Flow Cytometry

Relative percentages of CD3 + CD8 bright (A), CD3 + CD8 dull (B), total CD3 + CD8 + (C) and CD3 - CD8 dull cells (D) in PBMC of newly diagnosed (ND, circle dots) vs long-term T1D patients (LT, square dots); horizontal bars, average values are reported.

Journal: PLoS ONE

Article Title: Identification of GAD65 AA 114-122 reactive 'memory-like' NK cells in newly diagnosed Type 1 diabetic patients by HLA-class I pentamers

doi: 10.1371/journal.pone.0189615

Figure Lengend Snippet: Relative percentages of CD3 + CD8 bright (A), CD3 + CD8 dull (B), total CD3 + CD8 + (C) and CD3 - CD8 dull cells (D) in PBMC of newly diagnosed (ND, circle dots) vs long-term T1D patients (LT, square dots); horizontal bars, average values are reported.

Article Snippet: A subsequent staining procedure for phenotypic characterization of CD3 - CD8 dull GAD65 AA 114–122 pentamer reactive T cells was implemented by adding the following antibodies: mAb anti-human CD8 FITC (1:20, BD), mAb anti-human CD3 Alexa Fluor 700-A labelled (1:50, clone UCHT1, cat# 557943, BD), mouse mAb anti-human CD56 PE cyanine 7 (PECy7) labelled (clone B159, cat# 557747, BD) and mouse mAb anti-human ILT2/LIR1 (CD85J (Ig-like transcript (ILT)/leukocyte Ig-like receptor (LIR) (APC conjugated, clone HP-F1, cat# 17-5129-41, eBioscience) [ ] both used at 1:50 dilution.

Techniques:

Relative percentages of CD3 - CD8 dull CD56 + and CD3 - CD8 dull CD56 + ILT2 + GAD65 AA 114–122 pentamer reactive cells in T1D patients vs healthy controls after GAD65 peptide stimulation. (A) Representative experiment showing the flow-cytometry gate strategy; (B) Summary of results of CD3 - CD8 dull CD56 + GAD65 AA 114–122 pentamer reactive cells obtained in 15 healthy donors (circle dots) and 15 T1D patients (square dots); (C) Summary of results of CD3 - CD8 dull CD56 + ILT2 + GAD65 AA 114–122 pentamer reactive cells. Horizontal bars, average values are reported.

Journal: PLoS ONE

Article Title: Identification of GAD65 AA 114-122 reactive 'memory-like' NK cells in newly diagnosed Type 1 diabetic patients by HLA-class I pentamers

doi: 10.1371/journal.pone.0189615

Figure Lengend Snippet: Relative percentages of CD3 - CD8 dull CD56 + and CD3 - CD8 dull CD56 + ILT2 + GAD65 AA 114–122 pentamer reactive cells in T1D patients vs healthy controls after GAD65 peptide stimulation. (A) Representative experiment showing the flow-cytometry gate strategy; (B) Summary of results of CD3 - CD8 dull CD56 + GAD65 AA 114–122 pentamer reactive cells obtained in 15 healthy donors (circle dots) and 15 T1D patients (square dots); (C) Summary of results of CD3 - CD8 dull CD56 + ILT2 + GAD65 AA 114–122 pentamer reactive cells. Horizontal bars, average values are reported.

Article Snippet: A subsequent staining procedure for phenotypic characterization of CD3 - CD8 dull GAD65 AA 114–122 pentamer reactive T cells was implemented by adding the following antibodies: mAb anti-human CD8 FITC (1:20, BD), mAb anti-human CD3 Alexa Fluor 700-A labelled (1:50, clone UCHT1, cat# 557943, BD), mouse mAb anti-human CD56 PE cyanine 7 (PECy7) labelled (clone B159, cat# 557747, BD) and mouse mAb anti-human ILT2/LIR1 (CD85J (Ig-like transcript (ILT)/leukocyte Ig-like receptor (LIR) (APC conjugated, clone HP-F1, cat# 17-5129-41, eBioscience) [ ] both used at 1:50 dilution.

Techniques: Flow Cytometry

The percentage of CD3 - CD56 + cells (A) and of CD3 - CD56 + ILT2 + cells (B) were assessed by flow cytometric analyses of IL-2 alone treated PBMC. NK cell phenotype of 14 healthy donors (HD, circle plots) was compared with that of 14 T1D patients (square dots); horizontal bars, average values are shown. No significant differences are reported (KS test, unpaired t test).

Journal: PLoS ONE

Article Title: Identification of GAD65 AA 114-122 reactive 'memory-like' NK cells in newly diagnosed Type 1 diabetic patients by HLA-class I pentamers

doi: 10.1371/journal.pone.0189615

Figure Lengend Snippet: The percentage of CD3 - CD56 + cells (A) and of CD3 - CD56 + ILT2 + cells (B) were assessed by flow cytometric analyses of IL-2 alone treated PBMC. NK cell phenotype of 14 healthy donors (HD, circle plots) was compared with that of 14 T1D patients (square dots); horizontal bars, average values are shown. No significant differences are reported (KS test, unpaired t test).

Article Snippet: A subsequent staining procedure for phenotypic characterization of CD3 - CD8 dull GAD65 AA 114–122 pentamer reactive T cells was implemented by adding the following antibodies: mAb anti-human CD8 FITC (1:20, BD), mAb anti-human CD3 Alexa Fluor 700-A labelled (1:50, clone UCHT1, cat# 557943, BD), mouse mAb anti-human CD56 PE cyanine 7 (PECy7) labelled (clone B159, cat# 557747, BD) and mouse mAb anti-human ILT2/LIR1 (CD85J (Ig-like transcript (ILT)/leukocyte Ig-like receptor (LIR) (APC conjugated, clone HP-F1, cat# 17-5129-41, eBioscience) [ ] both used at 1:50 dilution.

Techniques:

Degranulation of CD3 - CD56 + ILT2 + NK cells of PBMC from T1D patients, expanded with GAD65 AA 114–122 or FLU peptides, measured as CD107a cell-surface expression following stimulation with APCs, either left unpulsed or GAD65 AA 114–122 peptide-pulsed. (A) A representative experiment out of two performed is shown. K562 cells were used as positive control. The percentage of CD3 - CD56 + CD107a + NK cells (upper panel) and CD3 - CD56 + CD107a + ILT2 + (lower panel) is indicated for each condition. (B) Summary of CD3 - CD56 + CD107a + and (C) CD3 - CD56 + ILT2 + CD107a + NK cell percentage of four T1D PBMC, expanded with GAD65 AA 114–122 or FLU peptides, following stimulation with APCs, either left unpulsed (circle dots) or GAD65 AA 114–122 (GAD65)-pulsed (square dots); horizontal bars, average values are reported.

Journal: PLoS ONE

Article Title: Identification of GAD65 AA 114-122 reactive 'memory-like' NK cells in newly diagnosed Type 1 diabetic patients by HLA-class I pentamers

doi: 10.1371/journal.pone.0189615

Figure Lengend Snippet: Degranulation of CD3 - CD56 + ILT2 + NK cells of PBMC from T1D patients, expanded with GAD65 AA 114–122 or FLU peptides, measured as CD107a cell-surface expression following stimulation with APCs, either left unpulsed or GAD65 AA 114–122 peptide-pulsed. (A) A representative experiment out of two performed is shown. K562 cells were used as positive control. The percentage of CD3 - CD56 + CD107a + NK cells (upper panel) and CD3 - CD56 + CD107a + ILT2 + (lower panel) is indicated for each condition. (B) Summary of CD3 - CD56 + CD107a + and (C) CD3 - CD56 + ILT2 + CD107a + NK cell percentage of four T1D PBMC, expanded with GAD65 AA 114–122 or FLU peptides, following stimulation with APCs, either left unpulsed (circle dots) or GAD65 AA 114–122 (GAD65)-pulsed (square dots); horizontal bars, average values are reported.

Article Snippet: A subsequent staining procedure for phenotypic characterization of CD3 - CD8 dull GAD65 AA 114–122 pentamer reactive T cells was implemented by adding the following antibodies: mAb anti-human CD8 FITC (1:20, BD), mAb anti-human CD3 Alexa Fluor 700-A labelled (1:50, clone UCHT1, cat# 557943, BD), mouse mAb anti-human CD56 PE cyanine 7 (PECy7) labelled (clone B159, cat# 557747, BD) and mouse mAb anti-human ILT2/LIR1 (CD85J (Ig-like transcript (ILT)/leukocyte Ig-like receptor (LIR) (APC conjugated, clone HP-F1, cat# 17-5129-41, eBioscience) [ ] both used at 1:50 dilution.

Techniques: Expressing, Positive Control

Degranulation of CD3 - CD56 + ILT2 + NK cells of PBMC from HD patients, expanded with GAD65 AA 114–122 peptide, measured as CD107a cell-surface expression following stimulation with APCs, either left unpulsed or GAD65 AA 114–122 peptide-pulsed. A representative experiment out of two performed is shown. K562 cells were used as positive control. The percentage of CD3 - CD56 + CD107a + NK cells (upper panel) and of CD3 - CD56 + CD107a + ILT2 + (lower panel) is indicated for each condition.

Journal: PLoS ONE

Article Title: Identification of GAD65 AA 114-122 reactive 'memory-like' NK cells in newly diagnosed Type 1 diabetic patients by HLA-class I pentamers

doi: 10.1371/journal.pone.0189615

Figure Lengend Snippet: Degranulation of CD3 - CD56 + ILT2 + NK cells of PBMC from HD patients, expanded with GAD65 AA 114–122 peptide, measured as CD107a cell-surface expression following stimulation with APCs, either left unpulsed or GAD65 AA 114–122 peptide-pulsed. A representative experiment out of two performed is shown. K562 cells were used as positive control. The percentage of CD3 - CD56 + CD107a + NK cells (upper panel) and of CD3 - CD56 + CD107a + ILT2 + (lower panel) is indicated for each condition.

Article Snippet: A subsequent staining procedure for phenotypic characterization of CD3 - CD8 dull GAD65 AA 114–122 pentamer reactive T cells was implemented by adding the following antibodies: mAb anti-human CD8 FITC (1:20, BD), mAb anti-human CD3 Alexa Fluor 700-A labelled (1:50, clone UCHT1, cat# 557943, BD), mouse mAb anti-human CD56 PE cyanine 7 (PECy7) labelled (clone B159, cat# 557747, BD) and mouse mAb anti-human ILT2/LIR1 (CD85J (Ig-like transcript (ILT)/leukocyte Ig-like receptor (LIR) (APC conjugated, clone HP-F1, cat# 17-5129-41, eBioscience) [ ] both used at 1:50 dilution.

Techniques: Expressing, Positive Control